How Does the Bleeding Eye Virus Spread?
Marburg virus disease is a fast-moving, often fatal illness. Understanding its progression can aid in early detection and improve survival rates:
- Incubation Period: Symptoms typically appear abruptly, 2 to 21 days after infection.
- Early Symptoms: The disease begins with high fever, severe headache, and malaise. Muscle pain is also common.
- Gastrointestinal Phase: By day three, severe watery diarrhea, abdominal pain, cramping, nausea, and vomiting often occur. Patients in this stage are described as having “ghost-like” features, including sunken eyes, drawn expressions, and extreme lethargy.
- Hemorrhagic Symptoms: Between days five and seven, bleeding may begin, manifesting as:
- Bleeding from the nose, gums, or injection sites
- Blood in vomit and stool
- Spontaneous eye bleeding, lending the virus its nickname
“Being hemorrhagic, it damages blood vessels and causes bleeding—frequently from the eyes, nose, mouth, or vagina,” experts explain.
- Neurological Symptoms: Later stages may include confusion, irritability, and aggression.
- Fatal Outcomes: In severe cases, death occurs within eight to nine days after symptoms begin, often due to massive blood loss and shock.
How Can the Spread Be Prevented?
Preventing Marburg virus disease requires caution, especially in high-risk areas such as caves or mines inhabited by bats. Key measures include:
- Protective Gear: Wear gloves and masks to minimize exposure to infected bats or animals.
- Food Safety: Cook all animal products thoroughly to avoid transmission.
- Avoid Direct Contact: Refrain from handling the bodily fluids of infected individuals or contaminated materials like bedding and clothing.
- Isolation and Monitoring: Isolate suspected or confirmed cases and monitor exposed individuals for 21 days to limit further spread.
- Safe Burial Practices: Handle deceased individuals with care, as their bodies can remain infectious.
Travelers should avoid contact with potential animal carriers, such as Egyptian fruit bats and non-human primates, in affected regions.
Should You Be Concerned About the Marburg Virus in the U.S.?
With the recent outbreak in Rwanda, it’s natural to question whether Marburg poses a risk in the U.S. Fortunately, the CDC has assessed the risk to the general U.S. population as “low,” with “moderate confidence.”
The outbreak in Rwanda remains contained within specific clusters, with no evidence of widespread community transmission. Additionally, travel routes between Rwanda and the U.S. are limited, reducing the likelihood of the virus reaching American soil.
Even if a case were to emerge in the U.S., the country’s robust public health infrastructure is well-equipped to manage it. During the 2014-2015 Ebola outbreak, for instance, only two U.S. infections occurred, both of which were contained without further spread.
For most Americans, the situation calls for staying informed rather than alarmed. However, recent travelers to Rwanda should remain vigilant and adhere to health guidelines.
Is There a Cure or Vaccine for the Marburg Virus?
Currently, no approved cure or vaccine exists for MVD. However, promising research is underway. The Sabin Vaccine Institute, the International AIDS Vaccine Initiative (IAVI), and Oxford University (developers of the AstraZeneca COVID-19 vaccine) are among those advancing potential vaccine candidates, with trials already in progress.
In the absence of a cure, healthcare professionals rely on supportive care, such as rehydration and symptom management, to improve survival rates. Diagnosing MVD remains challenging, as its symptoms overlap with other diseases like malaria. Confirmation requires specialized diagnostic tools like antibody-capture ELISA tests.

Staying Vigilant Against the Marburg Threat
With its high mortality rate and rapid spread, the Marburg virus remains a serious global health concern. Its recent outbreaks emphasize the need for heightened awareness, effective prevention, and continued research into treatments.
By staying informed, practicing good hygiene, and following travel advisories, we can reduce risks and support global efforts to combat the Marburg virus. Prioritizing education and vigilance will help minimize its spread and protect public health.

